BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Prognosis
10 results:

  • 1. Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life.
    Lebret T; Bonastre J; Fraslin A; Neuzillet Y; Droupy S; Rebillard X; Vordos D; Guy L; Villers A; Schneider M; Coloby P; Lacoste J; Méjean A; Lacoste J; Descotes JL; Eschwege P; Loison G; Blanché H; Mariani O; Ghaleh B; Mangin A; Sirab N; Groussard K; Radvanyi F; Allory Y; Benhamou S
    BMJ Open; 2023 Dec; 13(12):e075942. PubMed ID: 38128940
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical prostatectomy With Positive Surgical Margins.
    Salles DC; Mendes AA; Han M; Partin AW; Trock BJ; Jing Y; Lotan TL
    Mod Pathol; 2023 Jul; 36(7):100147. PubMed ID: 36828362
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis.
    Alshalalfa M; Nguyen TT; Stopsack KH; Khan A; Franco I; Seldon C; Swami N; Jin W; Meiyappan K; Ton M; Venstrom JM; Dee EC; Mahal BA
    Urol Oncol; 2023 Feb; 41(2):106.e17-106.e23. PubMed ID: 36400666
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Role of Serum Creatinine Levels in Prognostic Risk Stratification of prostate cancer Patients.
    Gu X; Wu J; Liu X; Hong Y; Wu Y; Tian Y
    Med Sci Monit; 2022 Jul; 28():e937100. PubMed ID: 35864726
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy.
    Wang Y; Wu G; Fan L; Pan J; Gong Y; Fei X; Du X; Zhu Y; Xue W
    Prostate; 2021 Jun; 81(8):463-468. PubMed ID: 33822399
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Knockdown of FBP1 enhances radiosensitivity in prostate cancer cells by activating autophagy.
    Li XR; Zhou KQ; Yin Z; Gao YL; Yang X
    Neoplasma; 2020 Sep; 67(5):982-991. PubMed ID: 32453596
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration.
    Soria F; Giordano A; D'Andrea D; Moschini M; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Bensalah K; Mathieu R; Chlosta P; Babjuk M; Glybochko PV; Enikeev DV; Remzi M; Gust K; Gontero P; Shariat SF
    Urol Oncol; 2020 Jun; 38(6):602.e11-602.e19. PubMed ID: 32037197
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA).
    Cao Z; Wei L; Zhu W; Yao X
    Medicine (Baltimore); 2018 Mar; 97(12):e0182. PubMed ID: 29561434
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Familial versus sporadic prostate cancer in the German population. Clinical and pathological characteristics in patients after radical prostatectomy].
    Paiss T; Bock B; Gschwend JE; Heinz H; Vogel W; Kron M; Hautmann RE; Herkommer K
    Urologe A; 2003 Jul; 42(7):946-53. PubMed ID: 12898039
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.